een beetje uitleg over mijn nieuwe ziekte

Dag bloggers,hier is een kort fragment uit het internet,het is wel in het engels,hoop dat jullie er aan iut kunnen.
Several variants have recently been characterised according to the relative
distribution of clinical signs. “Encephalomyelitis with rigidity”
is characterised by a subacute course leading to death within three
years; “jerking stiff person syndrome” presents a predominant
brainstem involvement ad “stiff limb syndrome” is a focal
form with predominant involvement of the spinal cord.
A paraneoplastic variant has been described in association with breast
cancer in women harbouring anti-amphiphysin antibodies. In those patients
the onset of stiffness in upper limbs is suggestive of a paraneoplastic
aetiology. Autoimmunity to gephyrin, a cytosolic protein at post-synaptic
inhibitory synapses, has been described in association with undifferentiated
mediastinal tumour. SPS has also been reported in association with neoplasia
of the colon and lung, Hodgkin’s disease, thymoma.
Associated antibodies
Anti-GAD antibodies (figure1) are present in 60% of patients
and stain the axon hillocks of Purkinje cells and diffuse nerve terminals
in the molecular and granular layers of cerebellum. In addition, antibodies
to pancreatic islet cells, gastric parietal cells, thyroid microsomes,
and thyroglobulin are frequently found in patients positive for anti-GAD
antibodies. The relationship of autoantibodies to the pathogenesis of
the disease remains to be determined. Anti-GAD antibodies are also present
in patients with insulin dependent diabetes mellitus and autoimmune
polyendocrine syndrome but the anti-GAD level in these syndromes is
usually much lower than in SPS.
Anti-amphiphysin antibodies:
(figure 2) are directed to a 128 kd neuronal protein concentrated in
nerve terminals. Rare paraneoplastic SPS present anti-GAD antibodies
alone or associated with anti-amphiphysin antibodies.
Treatment
Benzodiazepines are an effective therapy for SPS because they modulate
the levels and activity of GABA. A similar mode of action has been proposed
for baclofen, which can be administered orally or via an intrathecal
route. Sodium valproate and vigabatrin are found to be effective therapies
for a few patients; the mechanism of action may be to potentiate GABAergic
synaptic transmission.
Immunosuppressive agents such as steroids, azathioprine; plasmapheresis
and intravenous immunoglobulin are also effective.


